Clinical Trial Update: Healthy Donor Study II - Comparing Plerixafor With G-CSF and Plerixafor [Phase 2]

View source ↗

Summary

Phase 2 healthy donor study comparing plerixafor with G-CSF and plerixafor alone for stem cell mobilization; the trial is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Lymphoma

Drugs mentioned

• Filgrastim (filgrastim)
• Plerixafor (Plerixafor)

Snippet

Sponsor: Stephen Couban | Conditions: Malignant Lymphoma, Stem Cell Type | Phase 2 | Status: COMPLETED